Pancreatic Cancer Research

ResearcherIMU UniversityNo recent work listed

Li-Lian Gan

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-4175-8988; OpenAlex author ID A5001884387. Sources: OpenAlex.

Their work

Papers
2 (first author 1, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
5
Papers, trials and grants by year

2020: 1 paper · 2021: none · 2022: 1 paper

Papers 2

  1. Histone Deacetylase Inhibitors Restore Cancer Cell Sensitivity towards T Lymphocytes Mediated Cytotoxicity in Pancreatic Cancer. First author DOI 10.3390/cancers14153709↗
  2. Molecular Mechanisms and Potential Therapeutic Reversal of Pancreatic Cancer-Induced Immune Evasion. Co-author DOI 10.3390/cancers12071872↗

Closest collaborators

The 5 strongest of 5 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Chee‐Onn Leong · 2 shared papers, 2020–2022 · strength 0.31
  2. Ling‐Wei Hii · 2 shared papers, 2020–2022 · strength 0.31
  3. Chun‐Wai Mai · 2 shared papers, 2020–2022 · strength 0.31
  4. Wynne Sim · 1 shared paper, 2022 · strength 0.16
  5. Chin-King Looi · 1 shared paper, 2022 · strength 0.16

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.